From Wikipedia, the free encyclopedia

This article is about the biotech corporation. For the style fly tying, see Fly lure

Corixa was a biotechnology/pharmaceutical company based in Seattle, Washington involved in the development of immunotherapeutics to combat autoimmune diseases, infectious diseases, and cancer. It was founded in 1994. It operated a laboratory and production facility in Hamilton, Montana.

The name Corixa comes from the true bug (Insecta: Hemiptera: Heteroptera) genus Corixa (family Corixidae, Water boatman), described by Geoffroy, in 1762.

On 12 July 2005, the European pharmaceuticals giant GlaxoSmithKline completed the acquisition of Corixa. GSK had formerly made use of the Corixa's MPL adjuvant in some of their vaccines.

On 31 March 2006, Corixa's doors closed after over 11 years in business.

External links

• Corixa website

From Wikispecies

Taxonavigation

Main Page
Cladus: Eukaryota
Supergroup: Unikonta
Cladus: Opisthokonta
Regnum: Animalia
Subregnum: Eumetazoa
Cladus: Bilateria
Cladus: Nephrozoa
Cladus: Protostomia
Cladus: Ecdysozoa
Phylum: Arthropoda
Subphylum: Hexapoda
Classis: Insecta
Cladus: Dicondylia
Cladus: Pterygota
Cladus: Metapterygota
Cladus: Neoptera
Cladus: Eumetabola
Cladus: Paraneoptera
Superordo: Condylognatha
Ordo: Hemiptera
Subordo: Heteroptera
Infraordo: Nepomorpha
Superfamilia: Corixoidea
Familia: Corixidae
Subfamilia: Corixinae
Genus: Corixa
Species: C. affinis - C. dentipes - C. iberica - C. hieroglyphica - C. panzeri - C. punctata

Name

Corixa Geoffroy, 1762